No(subjects with fasting serum triglyceride levels 30-199 mg/dL)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Healthy males and females aged 20 to 64 years old (2)Subjects whose fasting serum triglyceride levels are from 30 mg/dL to 199 mg/dL (3)Subjects who can stop drinking from 2 days before each measurement (4)Subjects who can make self-judgment and are voluntarily giving written informed consent
Exclusion criteria
Exclusion criteria: (1)Subjects who use medications affecting obesity, hyperlipidemia, lipid metabolism, and so on (2)Subjects who can't stop using supplements and/or functional foods affecting obesity, hyperlipidemia, lipid metabolism, and so on (3)Subjects who contract serious diabetes, kidney disease, liver disease, and/or disease needing immediate treatment, and who are taking relevant medicines (4)Subjects who have a history of digestive disease affecting digestion and absorption, and related surgery (5)Subjects who are under treatment for or have a history of drug addiction and/or alcoholism (6)Subjects who have been diagnosed as familial hyperlipidemia (7)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating (8)Subjects who have donated blood components and/or blood a volume of 200 mL and over within one month prior to the current study (9)Subjects who are planning to participate or already participating in other clinical studies (10)Subjects who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical examination, Hematological examination, urine analysis, vital signs | — |
Countries
Japan
Contacts
KSO Corporation Sales department